These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 157453)

  • 21. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal lymphocyte protein synthesis in bronchogenic carcinoma.
    Whitcomb ME; Parker RL
    Cancer; 1977 Dec; 40(6):3014-8. PubMed ID: 303935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between immune reactivity, serum cortisol, and stage of disease in patients with non-oat-cell bronchogenic carcinoma.
    DeMeester TR; Golomb HM; Dudek P; Hunter RL; Fang VS
    Surgery; 1979 Jul; 86(1):130-7. PubMed ID: 572099
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
    Das SN; Khanna NN; Khanna S
    Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic studies in bronchogenic carcinoma.
    Zeromski J
    Ann Med Sect Pol Acad Sci; 1974; 19(3-4):197-236. PubMed ID: 4616524
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immune stimulation with vitamin A therapy in patients with pulmonary neoplasms].
    Micksche M; Cerni C; Kokron O; Titscher R; Wrba H
    Onkologie; 1978 Apr; 1(2):57-62. PubMed ID: 362282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro lymphocyte blastogenesis: a prognostic test in patients with neoplastic disease.
    Han T
    J Surg Oncol; 1973 Jun; 5(6):567-74. PubMed ID: 4129688
    [No Abstract]   [Full Text] [Related]  

  • 29. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
    Murray JL; Reuben JM; Smith TL; Gehan EA; Koretz SM; Hersh EM
    J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Skin reactions with ubiquitous multiple antigens as a test of survival in patients with inoperable bronchogenic carcinoma].
    Giorgis GE; Oliaro A; Galietti F; Barberis S; Ardizzi A; Gallo E; Onoscuri E
    Minerva Med; 1988 Jun; 79(6):447-9. PubMed ID: 3380311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation.
    Simmler MC; Rameau G; Chou MJ; Mathé G
    Isr J Med Sci; 1976; 12(4-5):472-8. PubMed ID: 939695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant immunotherapy in bronchogenic carcinoma.
    Takita H; Minowada J; Han T; Takada M; Lane WW
    Ann N Y Acad Sci; 1976; 277(00):345-54. PubMed ID: 1069554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune reactivity in bronchogenic carcinoma and its relation to 5-year survival rate.
    Watanabe Y; Shimizu J; Hashizume Y; Tsunamura Y; Yamada T; Iwa T; Sakai S; Murayama T; Koshimura S; Saito M
    J Surg Oncol; 1990 Oct; 45(2):103-9. PubMed ID: 2214788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of radiotherapy on the immunocompetence in patients with bronchogenic carcinoma and laryngeal cancer (author's transl)].
    Oshitani T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(9):873-86. PubMed ID: 7335479
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunocompetence of patients with bronchogenic carcinoma.
    Olkowski ZL; McLaren JR; Mansour KA
    Ann Thorac Surg; 1976 Jun; 21(6):546-51. PubMed ID: 179484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary metastases, a potential biologic consequence of anesthetic-induced immunosuppression by thiopental.
    Lundy J; Lovett EJ; Conran P
    Surgery; 1977 Aug; 82(2):254-6. PubMed ID: 141748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin test in bronchogenic carcinoma. II. Its value in the differential diagnosis.
    Brugarolas A; Takita H; Vincent RG
    J Surg Oncol; 1973; 5(4):319-25. PubMed ID: 4745885
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
    Moertel CG; Ritts RE; Schutt AJ; Hahn RG
    Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cellular immunity in lung cancer].
    Miyamoto H; Inoue S
    Nihon Rinsho; 1980 Jul; 38(7):2761-9. PubMed ID: 6450844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.